The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $38.68

Today's change-0.07 -0.18%
Updated August 21 4:01 PM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $38.68

Today's change-0.07 -0.18%
Updated August 21 4:01 PM EDT. Delayed by at least 15 minutes.

GlaxoSmithKline PLC down (U.S.)$0.07

GlaxoSmithKline PLC closed lower Monday, dropping (U.S.)$0.07 or 0.18% to (U.S.)$38.68. Shares have lost 0.85% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 23.61% during the last year.

Key company metrics

  • Open(U.S.) $38.75
  • Previous close(U.S.) $38.75
  • High(U.S.) $38.82
  • Low(U.S.) $38.60
  • Bid / Ask-- / --
  • YTD % change+0.44%
  • Volume2,051,734
  • Average volume (10-day)2,460,404
  • Average volume (1-month)2,699,309
  • Average volume (3-month)2,811,419
  • 52-week range(U.S.) $37.20 to (U.S.) $44.54
  • Beta1.02
  • Trailing P/E43.98×
  • P/E 1 year forward13.64×
  • Forward PEG1.10×
  • Indicated annual dividend(U.S.) $2.49
  • Dividend yield6.43%
  • Trailing EPS(U.S.) $0.88
Updated August 21 4:01 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue7,3847,5867,5426,532
Total other revenue--------
Total revenue7,3847,5867,5426,532
Gross profit5,0325,2575,0994,476
Total cost of revenue2,3522,3292,4432,056
Total operating expense5,6666,9916,1116,683
Selling / general / administrative2,3472,4762,2322,075
Research & development9191,017876800
Depreciation / amortization11101110
Interest expense (income), net operating--------
Unusual expense (income)1191,2766561,825
Other operating expenses, total-82-117-107-83
Operating income1,7185951,431-151
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,5504231,274-318
Income after tax1,223317885-492
Income tax, total327106389174
Net income1,046257808-435
Total adjustments to net income--------
Net income before extra. items1,046257808-435
Minority interest-177-60-7757
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,046257808-435
Inc. avail. to common incl. extra. items1,046257808-435
Diluted net income1,046257809-435
Dilution adjustment--01--
Diluted weighted average shares4,8774,9574,9024,859
Diluted EPS excluding extraordinary itemsvalue per share0.210.050.17-0.09
Dividends per sharevalue per share0.190.230.190.19
Diluted normalized EPSvalue per share0.220.250.300.26